vcfirmsdirectory.com

Venture capital

Remiges Ventures

Remiges Ventures is a life-science focused venture firm with offices in Seattle and Tokyo. It backs therapeutics companies and runs RDiscovery, a drug discovery incubation fund.

Seattle · TokyoRegistered · Seattle
New investments · 12 months
Fund vehiclesPublic
3
3 active · US private fund
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: remigesventures.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round Remiges Ventures joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is Remiges Ventures right for your round?

Is Remiges Ventures a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
3
3 active · US private fund
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.

REMIGES BIOPHARMA FUND II, LPUS private fund · Active · Cayman Islands · $95M gross assets · filed 9 Jan 2026
REMIGES BIOPHARMA FUND, LPUS private fund · Active · Cayman Islands · $80M gross assets · filed 9 Jan 2026
RDISCOVERY FUND, LPUS private fund · Active · Cayman Islands · $50.6M gross assets · filed 9 Jan 2026
Deployed (new cheques)
Next fund expected

Latest investments

BetaRounds Remiges Ventures joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

1 round in the last 12 months

Round sizes, Remiges Ventures’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

Viage TherapeuticsOmeicos TherapeuticsKisoJi Biotechnology Inc.ENB TherapeuticsImel BioTherapeuticsPhost'in TherapeuticsLuca ScienceCyrano TherapeuticsGlycomineRestore Visionand 7 more

Portfolio and exits

Every company Remiges Ventures backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where Remiges Ventures puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet Remiges Ventures

Events where Remiges Ventures’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet Remiges Ventures’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

18 Mar 2026New deal
9 Jan 2026Fund filingForm ADV filed by REMIGES VENTURES, INC.: 3 private funds, $225.6M in gross assets.SEC Form ADV · public record
11 Jan 2025New deal

Founders also look at

Frequently asked questions

Remiges Ventures is based in Seattle, United States. It also has an office in Tokyo.

3 fund vehicles are on public registers (SEC adviser filings), including REMIGES BIOPHARMA FUND II, LP, REMIGES BIOPHARMA FUND, LP and RDISCOVERY FUND, LP.

Remiges Ventures lists 17 portfolio companies on its website, including Viage Therapeutics, Omeicos Therapeutics, KisoJi Biotechnology Inc., ENB Therapeutics and Imel BioTherapeutics.

Firms whose websites list some of the same companies include Advent Life Sciences, ANV MANAGEMENT, LLC and AWESOME ENABLERS, L.L.C..

Know before Remiges Ventures’s next round is announced.

PRO tracks Remiges Ventures’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

Remiges VenturesGet Remiges Ventures’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.